Support

During my career as an RRT, I have worked with thousands of oxygen users of every profile and diagnosis in the community. Some of the most common limitations of home oxygen include lack of duration, choice and clinical delivery range of portable oxygen devices, difficulty ensuring accurate oxygen delivery, and client independence coupled with the self-esteem issues some oxygen delivery systems can generate for the user. 
Making portable oxygen systems more reliable and efficient would improve these limitations. Clients would then be more inclined to use portable sources, allowing them to live more active lifestyles. Further, pulse-dosed oxygen can be sub-optimally delivered, with issues of bolus mistiming or absence during sleep and exercise. 
Oxygen users can benefit from improved, reproduceable timing of portable oxygen delivery. This can result in more confident. more mobile, and less anxious users of oxygen therapy. I believe Pulmvita's new nasal interface can positively impact changes in the oxygen market and improve the useful range of portable oxygen devices. 

I have seen the struggles of home oxygen users with compliance due to the equipment issues that relate back to minimizing the lifestyle impact – self-esteem of wearing oxygen, portability and reliability of oxygen delivery.  To allow for greater portability, oxygen equipment has decreased in size and work was done to create conserving devices to allow for this decrease.  Unfortunately, accurate delivery of oxygen to patients has been an ongoing challenge despite these advancements.   
The product being developed by Pulmvita shows great promise in providing patients with consistent oxygen delivery by allowing greater accuracy in timing of pulsed oxygen flow.  Less missed pulses mean reliable oxygen delivery which leads to improved oxygenation, increased ability to exercise and sleep as well as freedom to go about life in general with confidence knowing their oxygen needs are being met.  The patients who rely on oxygen could come away with increased compliance and ability to get the oxygen support they need allowing them to be more active both physically and socially. 

In my extensive experience working with thousands of oxygen users of every profile and diagnosis in the community, I have witnessed a range of common challenges. Among them is the lack of duration, choice, and clinical delivery range of portable oxygen devices, difficulty ensuring accurate oxygen delivery, and the self-esteem issues that can arise from using some oxygen delivery systems.

By making portable oxygen systems more reliable and efficient, we can overcome these limitations and enable clients to lead more active lifestyles. Additionally, pulse-dosed oxygen can be sub-optimally delivered, with issues of bolus mistiming or absence during sleep and exercise. The development of Pulmvita's new nasal interface can help address these challenges by providing improved, reproducible timing of portable oxygen delivery.

I firmly believe that this new technology has the potential to positively impact changes in the oxygen market and improve the useful range of portable oxygen devices. Oxygen users will benefit from greater confidence, mobility, and reduces anxiety when using this therapy.